Literature DB >> 7608539

Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.

S Rich1, M Seelig, H M Lee, J Lin.   

Abstract

Transforming growth factor beta (TGF-beta) exhibits diverse effects on growth and differentiation of a wide range of cell types. In the immune system, TGF-beta 1 is a potent inhibitor of T cell proliferation and certain T cell effector functions. However, TGF-beta 1 also enhances growth of T cells, predominantly of naive phenotype, and induces their expression of selected cytokines. We have previously demonstrated that TGF-beta 1 costimulates growth of highly purified murine CD8+ T cells activated by immobilized anti-CD3 Ab. TGF-beta 1-costimulated CD8+ T cells rapidly express a memory phenotype, lose lytic function, and express a mixed cytokine pattern with IL-2, IFN-gamma, and appreciable IL-10, as well as TGF-beta 1. The present work examines the possibility that TGF-beta 1 similarly costimulates response of murine CD8+ T cells to the microbial superantigen staphylococcal enterotoxin B (SEB) and characterizes their effector and regulatory functions. TGF-beta 1 significantly enhances CD8+ T cell proliferation to SEB in the presence of MHC class II-positive APC and TGF-beta 1-primed CD8+ T cells are enriched for SEB-reactive V beta 8+ TCR expression. TGF-beta 1 priming also up-regulates a memory-like CD45RBlowCD44highMEL-14low phenotype. TGF-beta 1 priming inhibits development of SEB-specific lytic effector function by more than 90%. However, TGF-beta 1-primed CD8+ effector T cells express elevated levels of IL-10 and TGF-beta 1, variable IFN-gamma, and undetectable IL-4. Additionally, they exhibit growth inhibitory effector function of SEB-induced proliferation of other CD4+ and CD8+ T cells. Growth inhibition by TGF-beta 1-primed CD8+ T cells is reversed in part by anti-IL-10 Ab. Thus, in the context of SEB response, TGF-beta 1 promotes the outgrowth and induces the effector function of CD8+ T cells that have the capacity to impair T cell clonal growth.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608539

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Special regulatory T-cell review: Suppressors regulated but unsuppressed.

Authors:  Judith A Kapp
Journal:  Immunology       Date:  2008-01       Impact factor: 7.397

2.  The emergence of non-cytolytic NK1.1+ T cells in the long-term culture of murine tumour-infiltrating lymphocytes: a possible role of transforming growth factor-beta.

Authors:  K Tamada; M Harada; O Ito; M Takenoyama; T Mori; G Matsuzaki; K Nomoto
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

3.  Inhibitory effects of transforming growth factor-beta (TGF-beta) on certain functions of intraepithelial lymphocytes.

Authors:  E C Ebert
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

4.  The rs3761548 FOXP3 variant is associated with multiple sclerosis and transforming growth factor β1 levels in female patients.

Authors:  Tamires Flauzino; Daniela Frizon Alfieri; Wildea Lice de Carvalho Jennings Pereira; Sayonara Rangel Oliveira; Ana Paula Kallaur; Marcell Alysson Batisti Lozovoy; Damacio Ramón Kaimen-Maciel; Karen Brajão de Oliveira; Andrea Name Colado Simão; Edna Maria Vissoci Reiche
Journal:  Inflamm Res       Date:  2019-08-14       Impact factor: 4.575

5.  Effect of transforming growth factor beta on experimental Salmonella typhimurium infection in mice.

Authors:  M Galdiero; A Marcatili; G Cipollaro de l'Ero; I Nuzzo; C Bentivoglio; M Galdiero; C Romano Carratelli
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

Review 6.  TGF-β: guardian of T cell function.

Authors:  Soyoung A Oh; Ming O Li
Journal:  J Immunol       Date:  2013-10-15       Impact factor: 5.422

7.  Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1.

Authors:  L Z Chen; G M Hochwald; C Huang; G Dakin; H Tao; C Cheng; W J Simmons; G Dranoff; G J Thorbecke
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

8.  TGF-beta and regulatory T cell in immunity and autoimmunity.

Authors:  Yisong Y Wan; Richard A Flavell
Journal:  J Clin Immunol       Date:  2008-09-16       Impact factor: 8.317

9.  Presence of suppressor HIV-specific CD8+ T cells is associated with increased PD-1 expression on effector CD8+ T cells.

Authors:  Mohamed Elrefaei; Chris A R Baker; Norman G Jones; David R Bangsberg; Huyen Cao
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

10.  Cutting Edge: Tumor-specific CD8+ T cells infiltrating prostatic tumors are induced to become suppressor cells.

Authors:  Kimberly A Shafer-Weaver; Michael J Anderson; Katherine Stagliano; Anatoli Malyguine; Norman M Greenberg; Arthur A Hurwitz
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.